Browse Category

NASDAQ:LMND News 22 January 2026

Tesla stock rises in premarket as Musk flags “agonizingly slow” Cybercab, Optimus ramp and Lemonade bets on FSD

Tesla stock rises in premarket as Musk flags “agonizingly slow” Cybercab, Optimus ramp and Lemonade bets on FSD

NEW YORK, Jan 22, 2026, 09:21 (EST) — Premarket Tesla shares climbed about 1.2% to $436.78 in premarket trading Thursday, following a 2.9% gain on Wednesday that closed at $431.44. (The Wall Street Journal) The stock is now a test of how quickly Tesla can deliver on its ambitious self-driving and robotics goals with concrete results. Next week’s earnings report…
Lemonade stock rises again premarket as Tesla FSD insurance discount grabs attention

Lemonade stock rises again premarket as Tesla FSD insurance discount grabs attention

New York, Jan 22, 2026, 07:18 ET — Premarket Lemonade shares climbed 2.5% to $87.50 in premarket trading Thursday, following a 9.1% jump to $85.36 at Wednesday’s close. (StockAnalysis) This shift is significant, thrusting a modest insurer still operating at a loss into a larger conversation: how should car risk be priced as software takes over driving duties, and who…

Stock Market Today

  • 21Shares Launches Dogecoin Foundation-Backed DOGE ETF on Nasdaq
    January 22, 2026, 10:44 AM EST. 21Shares has launched a spot Dogecoin ETF, backed by the Dogecoin Foundation, debuting on Nasdaq under ticker TDOG. This marks the first ETF with official endorsement from the nonprofit overseeing Dogecoin since 2014, distinguishing it from earlier Bitwise and Grayscale offerings that lacked explicit SEC approval. The U.S. Securities and Exchange Commission granted regulatory clearance, confirming Dogecoin's status as not a security. 21Shares' president, Duncain Moir, anticipates the ETF will attract younger, affluent investors seeking exposure to crypto through traditional brokers. The launch supports efforts by the Dogecoin Foundation's corporate arm, House of Doge, to evolve the meme coin into a global payment platform. Moir acknowledges skepticism but stresses it underscores the product's unique appeal.
Go toTop